baber/WOPTO huggingface dataset:
Patent NZ-583295-A (NZ)
Title: Connecting to automation means over the internet using a protocol adaptation means
Inventor: GLEW DANIEL JOHN
IPC: H04L29/08
Filed: 2011-04-26
Abstract: Disclosed is an internet-based remote monitoring and control system. The system includes one or more automation means (103) located at one or more facilities, one or more communication means (105) located at one or more facilities, a service means (109) which interfaces with a protocol adaptation means and one or more interaction means (111). At least one internet-based first connection (115) is provided between one of the automation means (103) and the service means (109) and at least one second connection (117) is provided between the protocol adaptation means and one of the interaction means (111). The first connection (115) is facilitated through the communication means (105) which acts as a transparent proxy for the connection (115). The service means (109) makes the first connection(s) (115) available to the protocol adaptation means to enable transfer of automation means (103) monitoring and/or controlling data between the automation means (103) and the protocol adaptation means. The protocol adaptation means enables the second connection(s) (117) from the interaction means (111) and enables transfer of automation means (103) monitoring and/or controlling data between the automation means (103) and the interaction means (111). The protocol adaptation means further translates data received in the communication protocol of the interaction means (111) and/or vice-versa.
Patent NZ-588248-A (NZ)
Title: Use of a galactomannan such as guar gum to inhibit the uptake of polymeric quaternary ammonium compounds into hydrogel biomaterials
Inventor: KETELSON HOWARD ALLEN
IPC: C09K23/52
Filed: 2009-03-25
Abstract: Disclosed is the use of a galactomannan (such as guar gum, locust bean gum, tara gum and chemically modified derivatives thereof) to inhibit the uptake of polymeric quaternary ammonium compounds into hydrogel biomaterials, wherein an uptake-inhibiting amount of a galactomannan is added to a composition containing a polymeric quaternary ammonium compound and a borate.
Patent NZ-591896-A (NZ)
Title: Compositions and methods of treating amyloid disease
Inventor: BARDEN CHRISTOPHER J
IPC: A61K31/497
Filed: 2009-08-28
Abstract: 591896 COMPOSITIONS AND METHODS OF TREATING AMYLOID DISEASE The disclosure is directed to compounds of formulas Ia, Ib and Ic that inhibit amyloid aggregation and methods of treatment therewith. Examples of the claimed compounds include: N-methyl-5-(4-benzoylpiperazin-1-yl)-2-nitro-N-phenylbenzenamine, 2-(benzyl amino)-N,N-dimethyl-4-(4-benzoylpiperazin-1-yl)benzamide, 2-(benzylamino)N-ethyl-4-(4-benzoylpiperazin-1-yl)benzamide, 4-(4-benzoylpiperazin-l-yl)-N1-(2-morpholinoethyl)-N2-phenylbenzene-1,2-diamine, (4-(3-(N-methyl-N-phenylamino)-4-(dimethyl amino )phenyl)piperazin-1-yl)(phenyl)methanone and [4-(1, 1-dimethylethyl)phenyl][4-[4-nitro-3-[(phenylmethyl)amino]phenyl]-1-piperazinyl]methanone. The compounds are used in treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases.
Patent NZ-595102-A (NZ)
Title: An electronic equipment cabinet with fan for ventilating front to rear and heat pump cooling of front panel with evaporator and filter on front door of cabinet
Inventor: GEE BERNARD MICHAEL
IPC: H05K7/20
Filed: 2009-11-05
Abstract: There is provided an electronic equipment cabinet including a cabinet carcass (15) mounting fan cooled equipment (16) venting to the cabinet rear. A hinged front closure assembly (11) includes a frame (14) and an outer filter and perforated metal screen assembly on the outer face of the frame, and a lower condensation trap (20). The frame 14 supports an evaporator assembly (11) connected to a remote compressor/condenser assembly (not shown). The evaporator assembly includes a combined dew point sensor and thermostat (13). A non-woven filter web (19) acts a micro-droplet catcher on the inner face of the door assembly.
Patent NZ-601987-A (NZ)
Title: Method for recycling sheet material coated with a release agent and uses of the thus recycled material
Inventor: VERHASSELT BART
IPC: E04B1/80
Filed: 2011-03-01
Abstract: A method for treating waste material is disclosed. Release coated cellulose or polymeric sheets, consisting of liners for holding self-adhesive labels or films, are collect from producers and end users in the form of dense, bulky masses (29a), such as rolls and stacks. The collected material is then mixed and prepared by separating foreign bodies, such as metals etc. The prepared material is then fed to a dry-grinding station where it is dry-shredded and dry-ground into small pieces. Use of the dry-shredded recycled material obtained by the aforementioned method is also disclosed. The dry-shredded recycled material may be used in hydroseeding or hydromulching applications, as thermal and/or acoustic insulation, as a casing soil or plant growing medium, as a heat storage means, or as water absorbent medium.
Patent NZ-602512-A (NZ)
Title: Treatment of lupus arthritis using laquinimod
Inventor: HAVIV ASI
IPC: A61K31/47
Filed: 2011-03-02
Abstract: Disclosed herein is a use of laquinimod or pharmaceutically acceptable salt thereof, particularly laquinimod sodium in the manufacture of a medicament for treating a subject afflicted with active lupus arthritis, wherein the treatment comprises periodic administration (preferably oral administration) of the medicament to the subject for at least 12 weeks. The medicament may be formulated for use in combination with an effective amount of corticosteroid, immunosuppressive, antimalarial drug, non steroid anti-inflammatory drug, COX2 inhibitor, abatacept, rituximab and/or belimumab, wherein the amount of these drugs when taken together is effective to treat a subject afflicted with active lupus arthritis.
Patent NZ-603900-A (NZ)
Title: Subcutaneous anti-her2 antibody formulation
Inventor: ADLER MICHAEL
IPC: A61K9/00
Filed: 2010-07-28
Abstract: 603900 Disclosed is a highly concentrated, stable pharmaceutical liquid formulation of a pharmaceutically active anti-HER2 antibody for subcutaneous injection comprising: a. about 120 ± 18 mg/ml anti-HER2 antibody; b. about 1 to 50 mM ofa histidine buffer providing a pH of5.5 ± 0.6; c. about 1 to 500 mM of a stabilizer or a mixture of two or more stabilizers; and d. about 0.01 to 0.08 % of a nonionic surfactant; with the proviso that the formulation does not include a hyaluronidase enzyme at a concentration of > 150 to 16,000 U/ml.
Patent NZ-613534-A (NZ)
Title: Process and apparatus for the measurement of the hardness and for the selection of agricultural products
Inventor: BENEDETTI LUCA
IPC: G01N33/02
Filed: 2012-03-22
Abstract: A method for the selection of agricultural products, such as fruit, is disclosed. The method comprises measuring one or more indexes (S3, S4) through a non-destructive test on the agricultural product, and selecting the agricultural product on the basis of a determination of the hardness of the agricultural product. The hardness of the agricultural product is determined by comparison of the one or more indexes (S3, S4) with a line representative of a linear correlation between the one or more indexes and the hardness (Du) of the same agricultural product, as measured by a respective penetration test. A further method for the measurement of the hardness and for the selection of agricultural products, including implementing a test program to identify and select an agricultural product, is also disclosed.
Patent NZ-616027-A (NZ)
Title: Method for modulating cytokine activity
Inventor: UENO RYUJI
IPC: A61P37/02
Filed: 2012-04-18
Abstract: Disclosed herein is the use of 15-oxo prostaglandin fatty acid derivatives (prostones) for the manufacture of a medicament for treating esophagitis in a mammalian subject, wherein the fatty acid derivative is (-)-7-[(2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl]heptanoic acid (lupiprostone/SPI-0211), (-)-7-{ (2R,4aR,5R,7aR)-2-[(3S)-1,1-difluoro-3-methylpentyl-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl} heptanoic acid (cobiprostone), or (-)-7-[(1R,2R)-2-(4,4-difluoro-3-oxooctyl)-5-oxocyclopentyl]heptanoic acid. The disclosure also relates to the use of the compounds for modulating cytokine activity.
Patent NZ-616569-A (NZ)
Title: Cartridge, medical apparatus and method
Inventor: ENGLISH STUART
IPC: A61N5/06
Filed: 2012-02-22
Abstract: An illuminating cartridge (1) and complementary holding element (2) used in the treatment of eye diseases is disclosed. The cartridge and a holding element are for operable connection with each other to form a phototherapy apparatus (10). The cartridge includes a radiation source for emitting radiation towards an area to be treated of a user; a mount element for positioning the radiation source in a predetermined position relative to the area to be treated; wherein the mount element comprises a locating portion configured for locating the cartridge at a predetermined position with respect to a body portion of the user. It has been found useful to administer the radiation to the eye area by providing a mask type of device for a patient to wear during sleep, the mask configured to be secured over the patient’s head to cover the eye area, and adapted to include light emitting sources in the region of the eyes. The light sources may be LEDs or OLEDs, for example, and are arranged to emit light towards the eye area. For diabetic retinopathy, preferably light having a wavelength of between around 460 to 550 nm is administered to the eyes or eyelids, which corresponds to the scotopic sensitivity of the eye.
Patent NZ-616768-A (NZ)
Title: New process for the synthesis of (2e)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Inventor: GONZALEZ JOSE LORENZO
IPC: C07D223/16
Filed: 2013-10-17
Abstract: Disclosed is a process for the synthesis of 3,4-dimethoxy-cinnamonitrile / (2E)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile as represented by the compound of formula (I), characterised in that 4-bromo-1,2-dimethoxybenzene of formula (IX) is subjected to a coupling reaction with acrylonitrile in an organic solvent, in the presence of: i) a palladium catalyst (such as palladium(II) acetate, palladium on carbon, and palladium(II) chloride); ii) a ligand such as triphenylphosphine or tri(o-tolyl)phosphine; iii) a base such as triethylamine, sodium acetate, sodium carbonate or potassium carbonate; and iv) a phase transfer agent such as tetrabutylammonium bromide or tetrabutylammonium chloride. Also disclosed is the use of 3,4-dimethoxy-cinnamonitrile obtained by the above method, in the synthesis of ivabradine, and pharmaceutically acceptable salts thereof.
Patent NZ-623146-A (NZ)
Title: Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
Inventor: MACDONALD LYNN
IPC: C07K14/705
Filed: 2012-10-26
Abstract: Disclosed is a non-human animal comprising at an endogenous Major Histocompatibility Complex II (MHC II) α gene locus a nucleotide sequence encoding a chimeric human/non-human MHC II α polypeptide and/or comprising at an endogenous MHC II β gene locus a nucleotide sequence encoding a chimeric human/non-human MHC II β polypeptide, wherein a human portion of the chimeric human/non-human MHC II α polypeptide comprises a human MHC II α2 extracellular domain, and/or a human portion of the chimeric human/non-human MHC II β polypeptide comprises human MHC II β2 domains, and wherein the animal expresses a functional MHC II complex on a surface of a cell of the animal.
Patent NZ-624052-A (NZ)
Title: Balloon with illuminating/sounding device
Inventor: HENRIK BO STIELER
IPC: F21V33/00
Filed: 2012-01-04
Abstract: A balloon with an illuminating/sounding device comprising a balloon body and an illuminating/sounding device, wherein the illuminating/sounding device is wholly within the balloon body and secured onto a wall of the balloon body via an external cover. The illuminating/sounding device is not in direct contact with the external cover. The balloon is secured with the illuminating/sounding device via the external cover so as to facilitate the fitting and installation of the illuminating/sounding device, to simplify the fitting structure for the illuminating/sounding device, and to reduce the manufacturing costs thereof, without affecting the inflation and use of the balloon.
Patent NZ-708504-A (NZ)
Title: Dual-filter dual-integrity test assembly
Inventor: HELLE KEVIN M
IPC: B01D39/00
Filed: 2013-12-26
Abstract: A dual-filter dual-integrity test conduit assembly and method which provides for individual in-situ testing of two filters used for dispensing product liquids, such that if one filter fails its integrity test, the integrity of the other filter is not affected. The system comprises two independent filter test circuits, one associated with each respective filter, and valves including three-port valves so that the fluid flowing through a filter can be selected between a medical fluid such as a nitrogen supply, or from and to a respective inlet and outlet of the product fluids.
Patent NZ-712221-A (NZ)
Title: Methods and devices to reduce the likelihood of injury from concussive or blast forces
Inventor: SMITH DAVID W
IPC: A61B17/132
Filed: 2014-03-14
Abstract: A system for applying pressure to the neck veins of a subject comprising a pair of devices attached to each other by a removable tether sized to facilitate spacing and alignment of each device over a neck vein. Each device comprises a flexible material contacting less than half the circumference of the neck and has inwardly directed protuberances contacting an inner surface of the flexible material. The inner surface of the flexible material extends beyond the protuberances which restrict blood flow egressing from the head. Also a device for applying pressure to the neck veins of a subject comprising a resilient arcuate band having a general C, V, or U-shape and sized to encircle less than half the neck, and inwardly directed protuberances. The resilient arcuate band comprises an adhesive and is configured to apply pressure to the protuberances to restrict blood flow egressing from the head.
Patent NZ-712369-A (NZ)
Title: 5-amino-quinoline-8-carboxamide derivatives as 5-ht4 receptor agonists
Inventor: NIROGI RAMAKRISHNA
IPC: C07D405/14
Filed: 2013-10-18
Abstract: The present invention relates to quinoline compounds of formula (I), and their pharmaceutically acceptable salts and process for their preparation. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptor agonists.
Patent NZ-713972-A (NZ)
Title: Use of a neuregulin to treat peripheral nerve injury
Inventor: BELLA ANTHONY J
IPC: A61P25/02
Filed: 2010-10-14
Abstract: Disclosed herein is the use of a neuregulin for treating an existing peripheral nerve injury in a subject, wherein the peripheral nerve injury is the result of a trauma or medical procedure, wherein the trauma is due to a crush injury or a surgical procedure, and wherein the surgical procedure is a radical pelvic surgery for prostate cancer, bladder cancer or rectal cancer, and wherein the surgical procedure may be a tumor resection surgery including prostatectomy, a breast cancer surgery or a complete or partial mastectomy. The neuragulin is preferably GGF2 or an active fragment thereof.
Patent NZ-714954-A (NZ)
Title: Herbicidal composition having improved plant safety
Inventor: YAMADA RYU
IPC: A01P13/02
Filed: 2014-06-26
Abstract: Provided is a herbicidal composition which exhibits high herbicidal effect on undesired plants independently of meteorological conditions, soil conditions, the kind of crops, the timing of application and so on, while keeping the safety to useful plants. A herbicidal composition which contains both (1) 1-(1-ethyl-4-(3-(2-methoxyethoxy)-2-methyl-4-(methyl- sulfonyl)benzoyl)-1H-pyrazol-5-yloxy)ethyl methyl carbonate or a salt thereof and (2) at least one compound selected from the group consisting of fenchlorazole-ethyl, isoxadifen-ethyl, mefenpyr-diethyl, cloquintocet-mexyl and cyprosulfamide.
Patent NZ-729243-A (NZ)
Title: Novel glycan conjugates and use thereof
Inventor: WONG CHI-HUEY
IPC: C07K14/33
Filed: 2015-08-21
Abstract: This disclosure relates to an immunogenic composition comprising (a) a glycan conjugate comprising at least one glycan with a link and a carrier wherein the or each glycan is conjugated to the carrier through the linker, and (b) optionally an adjuvant. The or each glycan with the linker has a chemical structure of formula (II) wherein R1 is selected from the group consisting of –F, -N3, -NO2, and ORA where RA is an optionally substituted aryl, and R2 is –CH3; or R1 is –OH, and R2 is selected from the group consisting of –CH2F, -CH2N3, -CH2OH, and –C=CH.
Patent NZ-735558-A (NZ)
Title: Lock devices, systems and methods
Inventor: MCKIBBEN AARON
IPC: E05B81/72
Filed: 2013-01-30
Abstract: Refined iterative methods 400 for auto-handing electromechanical door locks are disclosed. The lock mechanism position is detected 401 to ascertain whether the lock is installed in a left 414 or right 412 hand configuration. If this doesn’t work the lock motor is activated in one direction 440 and the lock mechanism position is detected to again determine the installed configuration 422 or 423, or the motor might stall 424. If the configuration still cannot be detected and the motor stalls, then either an error signal is generated, or the motor is activated to drive the bolt in the other direction, and again the lock mechanism position is detected so as to determine the lock configuration or the motor might stall again.
Patent NZ-738875-A (NZ)
Title: Motile sperm domain containing protein 2 and cancer
Inventor: MENDEL ITZHAK
IPC: A61K35/13
Filed: 2016-07-29
Abstract: Disclosed herein are methods of treating, reducing the incidence of, or preventing one or more activities in or of a cancer cell, methods of treating, reducing the incidence of, or preventing migration or metastasis of a cancer cell, methods of treating, reducing the incidence of, or preventing a cancer by reducing tumor associated macrophages (TAMs) or their migration, and methods of treating, reducing the incidence of, or preventing a cancer (including metastatic cancer), for example, with an inhibitor of Motile Sperm Domain containing Protein 2 (MOSPD2). Also disclosed are inhibitors of MOSPD2 (e.g., anti-MOSPD2 antibodies or antigen binding fragments thereof) and pharmaceutical compositions containing MOSPD2 inhibitors. Also disclosed are methods for the prediction, diagnosis, or prognosis of cancer, cancer metastasis, tumor progression, or tumor invasiveness in a subject.
Patent NZ-741172-A (NZ)
Title: Power cable of aluminium coated with a tetrazole compound corrosion inhibitor
Inventor: DE MARTINO PAMELA
IPC: C23F11/14
Filed: 2015-09-25
Abstract: The present invention relates to a power cable comprising a metallic electric conductor surrounded by one or more semiconductive layer and one or more insulating layer, said cable having at least one metallic element made of aluminium, wherein a corrosion inhibitor is provided in direct contact with said at least one metallic element made of aluminium, and wherein said corrosion inhibitor is a corrosion inhibitor of formula (I).
Patent NZ-749512-A (NZ)
Title: Compositions and methods for the treatment of cancer
Inventor: KANDULA MAHESH
IPC: C07H19/067
Filed: 2017-05-12
Abstract: The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula VI may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treat cancer, neoplasm, and skin diseases.
Patent NZ-755710-A (NZ)
Title: Combinations of lysobactin and aminoglycosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals
Inventor: Köbberling Johannes
IPC: A61P31/04
Filed: 2018-02-14
Abstract: The present invention relates to the combination of lysobactin with an aminoglycoside antibiotic for use in the treatment of diseases caused by Gram-positive and Gram-negative bacteria in non-human animals. The invention proved to be particularly useful relating to the treatment of mastitis in non-human animals. Particularly bovine mastitis can be well addressed by the present invention.
Patent NZ-759608-A (NZ)
Title: Process for the preparation of (s,s)-secoisolariciresinol diglucoside and (r,r)-secoisolariciresinol diglucoside
Inventor: LI KE
IPC: A61K31/085
Filed: 2018-06-11
Abstract: Provided is a synthesis process for (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside.
Patent NZ-759764-A (NZ)
Title: Glucuronide prodrugs of janus kinase inhibitors
Inventor: HUDSON RYAN
IPC: C07D487/04
Filed: 2018-05-22
Abstract: The invention relates to glucuronide prodrug compounds of Janus kinase (JAK) inhibitors having formula (I), where W1, R1 and A1 are as defined. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds to treat gastrointestinal inflammatory diseases; and processes and intermediates for preparing such compounds.
Patent NZ-760782-A (NZ)
Title: Self-powered computing buoy
Inventor: MOFFAT BRIAN LEE
IPC: H02J4/00
Filed: 2018-07-13
Abstract: A computing apparatus that is integrated within a flotation module, the system obtaining the energy required to power its computing operations from waves that travel across the surface of a body of water on which the flotation module sets. Additionally, the self-powered computing apparatus employs novel designs to utilize its close proximity to the body of water and/or to strong ocean winds to significantly lower the cost and complexity of cooling their computing circuits.
Patent NZ-763993-A (NZ)
Title: Device that can be held on one hand for electrically assisted skin treatment, additional part for said device and blister for said additional part
Inventor: GIMELLI BRUNO
IPC: A61N1/30
Filed: 2018-10-11
Abstract: The aim of the invention is to simplify the handling of a skin treatment device (1). This aim is achieved, according to the invention, in that a ring (10), on which a carrier material for an active substance is impregnated, is plugged on the cap (5) of the device, which forms the skin electrode (4). Said carrier material preferably has the shape of a strip (13) and is stretched over the head of the cap (5), which is placed on the skin. As a result, an exactly metered quantity of active substance is located between the skin electrode (4) and the skin. Since the arcs (12) of the oval ring (10) are exposed, the latter can be gripped there without the hands being smeared with the cream carrying the active substance. The rings (10) having the impregnated carrier materials are provided in blisters (20).
Patent NZ-768019-A (NZ)
Title: A control device for an electronic aerosol provision system
Inventor: MOLONEY PATRICK
IPC: A24F40/65
Filed: 2019-03-27
Abstract: A control device for an electronic aerosol provision system is provided. The control device is configured to receive a replaceable component to form an electronic aerosol provision system. The control device includes a communication interface for performing communications external to the electronic aerosol provision system; a memory configured to hold a set of stored identifiers; and a control system. The control system is configured to: receive control information from a remote server via the communication interface; update the set of stored identifiers based on the control information received from the remote server; receive an identifier from a replaceable component received by the control device; make a comparison of the received identifier against the set of stored identifiers; and perform a control action for the electronic aerosol provision system dependent upon the result of said comparison.